Primary Chemotherapy in Patients With HER2-positive Early Breast Cancer (LAPADO)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01172223
Recruitment Status : Completed
First Posted : July 29, 2010
Last Update Posted : November 2, 2016
Information provided by (Responsible Party):
Prof Dirk Elling, Sana-Klinikum Lichtenberg

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : January 2013
  Actual Study Completion Date : December 2013